An immunohistochemical study showed that eIF3d is overexpressed in grade-1 and 2 GB brain tumors and U251 and U-87 MG glioma cells (Ren et al., 2015), and when eIF3d was knocked out, the cell proliferation and colony formation decreased. Here, EIF3D is linked to central nervous system cancer.